Related Experiment Video
Updated: Feb 2, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Dynamics and Challenges of Clinical Trials in Adolescents and Young Adults With Cancer
Abstract:
Inclusion in cancer clinical trials is considered the optimal standard of care, offering improved patient experience and progressive survival gains for subsequent generations of patients. Adolescent and young adult (AYA) patients are underrepresented in cancer research; consequently, improvements in outcomes for AYAs lag behind their pediatric and adult counterparts. Despite international evidence of underrepresentation in research, systematically tested interventions to improve recruitment for AYAs do not exist, and recruitment rates for AYAs continue to be lower than those for children. We review recruitment of AYAs into trials and discuss barriers and facilitators.
Insights
Adolescent and young adult cancer patients are underrepresented in clinical trials, hindering outcome improvements. This review examines barriers and facilitators to enhance adolescent and young adult (AYA) recruitment in cancer research.
Area of Science:
- Oncology
- Clinical Trials
- Adolescent and Young Adult (AYA) Health
Background:
- Clinical trial participation is the standard of care for cancer patients, improving outcomes.
- Adolescent and young adult (AYA) cancer patients are significantly underrepresented in research.
- Outcome improvements for AYAs lag behind pediatric and adult populations due to low trial enrollment.
Purpose of the Study:
- To review the recruitment of adolescent and young adult (AYA) patients into cancer clinical trials.
- To identify and discuss barriers contributing to AYA underrepresentation.
- To explore facilitators that can improve AYA enrollment in cancer research.
Main Methods:
- Systematic review of existing literature on AYA cancer clinical trial recruitment.
- Analysis of identified barriers and facilitators impacting enrollment rates.
- Discussion of evidence-based strategies to improve AYA participation.
Main Results:
- AYA cancer patients face unique barriers to clinical trial participation.
- Systematically tested interventions to improve AYA recruitment are lacking.
- Recruitment rates for AYAs remain lower than for pediatric populations.
Conclusions:
- Addressing AYA underrepresentation in cancer trials is critical for advancing their care.
- Developing and implementing targeted interventions can improve AYA enrollment.
- Facilitating AYA participation in clinical trials is essential for equitable progress in cancer research.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Revisionist Views of Adolescent and Adult Cognition
Statistical Software for Data Analysis and Clinical Trials
Cognitive Development During Adolescence
Trial and Error and Algorithm

